Liver-receptor imaging injection, dispensing method and pharmaceutical composition thereof
US-9040017-B2 · May 26, 2015 · US
US10925981B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10925981-B2 |
| Application number | US-201816200833-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 27, 2018 |
| Priority date | May 9, 2018 |
| Publication date | Feb 23, 2021 |
| Grant date | Feb 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, a method for radiolabeling a hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor with Ga-68, and a hexa-lactoside PET imaging agent for a liver receptor. The hexa-lactoside-NOTA derivative is a conjugate of six chains of lactose with NOTA obtained by conjugating hexa-lactoside to a chelating agent p-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid in the presence of triethyl amine/dimethyl formamide as a solvent. The radiolabeling method comprises labeling with Ga-68 at room temperature. According to the present invention, the labeling effect is stable, the labeling efficiency of the labeled product is greater than 95%, the labeled product is highly stable and the radiochemical purity is still greater than 90% after 4 hours.
Opening claim text (preview).
What is claimed is: 1. A hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, having a structure of: 2. A hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor, having a structure of: 3. The imaging agent according to claim 2 , which is prepared by the steps of: reacting 3-valent Ga-68 and a triazanonane triacetic acid (NOTA) conjugate of six chains of lactose with sodium acetate buffer in a freeze drying ampoule at room temperature.
Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids · CPC title
Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00) · CPC title
Isotopically modified compounds, e.g. labelled · CPC title
conjugates with carriers being macromolecules · CPC title
Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.